Plant Viruses Found to Potentially Treat Diabetes, ArthritisMay 20, 2020
An Italian research team investigated the design and synthesis of plant virus nanoparticles with peptides associated with diabetes and rheumatoid arthritis. Their goal is to re-engineer nanoparticles and unravel therapeutic benefits for both autoimmune diseases.
The scientific team is led by the University of Verona with the help of the John Innes Centre who developed constructs of the cowpea mosaic virus to target diabetes. Peptides were also inserted into the peptide sequence of the tomato bushy stunt virus to obtain the chimeric particles and use it against rheumatoid arthritis. Plant viruses are known to have self-assembling nanostructures with versatile and genetically programmable shells. Their virus nanoparticles (VNPs) can be programmed to incorporate sequences for specific functions.
The scientists were able to observe that VNPs have the potential to modulate immune system response. Using animal models to test the responses, they found out that the peptide-related mechanism in which the VNPs act as both scaffold and adjuvant have an overlapping mechanism of action, therefore supporting the idea that recombinant nanoparticles can prevent diabetes and improve arthritis. This is an opportunity for further research on plant viruses being used for the clinical treatment of human autoimmune diseases.
You might also like:
- Biotechnology to Possibly Address Forest Health Problems
- Plant Enzyme Could Guide Development of Medicines and Other Products
- UPenn Develops Lettuce That Stimulates Bone Building Cells
The Crop Biotech Update is a weekly newsletter of ISAAA, a non-for-profit organization. The CBU is distributed for free to over 23,000 subscribers worldwide to inform them about the key developments in biosciences, especially in agricultural biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10.
See more articles:
- Medicago Announces Positive Results of Trials for its COVID-19 Vaccine Candidate
News from Around the World
- ISAAA Monitors Progress of Research on COVID-19
- Kenyan Researchers Seek Approval to Introduce Disease-Resistant Cassava
- ARS Scientists Identify Genes Associated with Postharvest Deterioration of Fresh-Cut Lettuce
- USDA Finalizes SECURE, Eases Up Biotech Regulations
- Scientists Solve 20-Year Old Wheat Genetics Puzzle
- South Australia Moves Closer to Planting GM Crops
- EFSA Releases Scientific Opinion on Oilseed Rape MS11
- Plant Viruses Found to Potentially Treat Diabetes, Arthritis
Plant Breeding Innovations
- CRISPR-Cas12b/C2c1 Tested in Targeted Mutagenesis of a Dicot
Subscribe to CBU: